- Home
- Research
Research
At the intersection of
clinical medicine
and research.
Dr. Bhaduri's academic and clinical research interests lie at the interface of endocrinology, metabolism, lipidology and technology-driven healthcare.
Six interlocking lines of enquiry
Focus areas
These are not separate projects. They describe one question approached from several angles: how metabolic disease damages organs over time, and what can be done earlier.
-
Cardio-renal-metabolic interrelationships
In type 2 diabetes and obesity — how glycaemic, cardiac and renal decline drive one another, and where intervention interrupts the sequence.
-
GLP-1 receptor agonists & dual incretin therapies
Clinical application in diabetes and obesity management, including effects that extend beyond glycaemia and weight.
-
Artificial intelligence & digital health tools
Optimising diabetes care and clinical decision support, and the regulatory and ethical questions that come with mobile health applications.
-
MASLD
Metabolic dysfunction-associated steatotic liver disease and its intersection with diabetes, including mechanistic work on the mitochondrial-autophagy axis and gut microbiota-derived metabolites.
-
Endocrine aspects of obesity & women's health
Including reproductive and metabolic outcomes, and differential treatment response.
-
Translational & outcomes research
Enhancing personalised management of diabetes and endocrine disorders in the Indian context.
From trial evidence to the consulting room
Method
Published work spans systematic reviews and meta-analyses, observational studies, mechanistic review and consensus statements.
Systematic reviews & meta-analyses
Pooled analyses on semaglutide and depression risk, empagliflozin in MASLD, and hypovitaminosis D among patients with diabetes in India.
Observational studies
Including a 12-month study of saroglitazar in patients with type 2 diabetes, MASLD and Stage 3 chronic kidney disease.
Mechanistic review
The mitochondrial-autophagy axis in MASLD, and gut microbiota-derived metabolites in disease progression.
Consensus & position statements
Consensus group member for the India-specific obesity consensus, testosterone replacement in diabetes, and mobile health applications for type 2 diabetes remission.
Research presented internationally
Presented
Selected presentations of original research at national and international congresses.
IDF World Diabetes Congress
Bangkok, Thailand
Prevalence and risk factors of hypovitaminosis D among T2DM patients from India: a systematic review and meta-analysis
PosterIDF World Diabetes Congress
Bangkok, Thailand
Effectiveness and safety of saroglitazar in patients with T2DM, MASLD and Stage 3 CKD: a 12-month retrospective study
PosterDiabetes India
India
Research presentation — awarded First Prize
AwardAmerican Diabetes Association — Scientific Sessions
Published in Diabetes 74(Suppl 1)
Insights from 1,062 clinicians: empagliflozin-linagliptin combination therapy in T2DM management
AbstractResearch roles & directorships
Leadership
Positions held in research organisations and national scientific committees.
- Director
- SHIFT MetaboTech Innovation — obesity and metabolic device innovation, research and collaboration
- Director
- Metabolic Research Foundation (MRF)
- Regional Director
- CPHHR — National Consortium for Public Health Research
- Programme Director
- Programme & Outreach Director, National Consortium for Metabolic Syndrome Research
- Committee
- Publication Committee member, National RSSDI · Scientific Core Committee, GSICON West Bengal Chapter, 2025
- Advisory
- National Advisor, Pregnancy Study Group in Diabetes (PSG InDia)
Research & collaboration
For academic correspondence, collaboration or speaking invitations, please get in touch by email.